The transforming growth factor-b (TGFb) superfamily controls a plethora of biological responses, and alterations in its signalling pathway are associated with a range of human diseases, including cancer. TGFb superfamily ligands signal through a heteromeric complex of Ser/ Thr kinase receptors that propagate the signal to the Smad family of intracellular proteins. The ubiquitinmediated proteasomal degradation pathway is an evolutionary conserved cascade that tightly regulates TGFb superfamily signalling. Both the size of the Smad pool in unstimulated cells and Smad protein levels subsequent to the activation of the pathway are controlled by ubiquitination. E3 ligases are components of the ubiquitin-degradation complex that specifically recognize targeted proteins and the E3 ligases, Smad ubiquitination-related factor 1 (Smurf1), Smurf2 and SCF/Roc1 have been implicated in Smad degradation. The Smurfs are of particular importance to TGFb signalling, as Smads also function as adapters that recruit the Smurfs to various pathway components including the TGFb receptor complex and the transcriptional repressor, SnoN, and thereby regulate the degradation of these Smad-associating proteins. Thus, by controlling the level of Smads as well as positive and negative regulators of the pathway, Smurfs provide for complex and fine control of signalling output. Finally, growing evidence demonstrates that ubiquitination and proteasomal degradation is also implicated in the turnover of tumor-derived Smad mutants and may thus contribute to disease progression. Oncogene (2004 Oncogene ( ) 23, 2071 Oncogene ( -2078 Oncogene ( . doi:10.1038 Keywords: smad; smurf; ubiquitination
TGFb signalling pathway
The transforming growth factor-b (TGFb) superfamily of cytokines control a plethora of biological responses and have been shown to play a prominent role during embryonic development, regulation of cell growth and differentiation and apoptosis (Massague´, 1998; Whitman, 1998; Derynck et al., 2001) . In addition, disruption or mutations in TGFb pathway components are associated with several human diseases, including cancer (de Caestecker et al., 2000; Derynck et al., 2001) . Approximately 40 distinct TGFb members have been identified in vertebrates and they are generally divided into two branches, the TGFb/activin/nodals and the bone morphogenetic proteins (BMPs), each of which can activate one of the two intracellular signalling cascades (de Caestecker et al., 2000; Moustakas et al., 2001; Attisano and Wrana, 2002; Shi and Massague, 2003) . Ligands initiate signalling by bringing together a complex of serine/threonine kinase receptors, consisting of the type I and type II class. Ligand binding triggers the phosphorylation of the type I receptor by the type II receptor kinase, which results in the activation of the type I kinase (Figure 1) . The signal is then transmitted from the type I receptor to the Smads, the intracellular effectors of the TGFb and BMP signalling pathways (Moustakas et al., 2001; Attisano and Wrana, 2002; Shi and Massague, 2003) . The type I receptor kinase directly phosphorylates two serine residues at the carboxyterminus of the receptor-regulated Smads or R-Smads, Smad1, -2, -3, -5 and -8. Smad1, -5 and -8 are phosphorylated by BMP type I receptors, while Smad2 and -3 are activated by the TGFb and activin type I receptors (Moustakas et al., 2001; Attisano and Wrana, 2002; Shi and Massague, 2003) . Phosphorylation of the R-Smads permits their association with the common Smad or co-Smad, Smad4. Once formed, this R-Smad/ Smad4 complex translocates to the nucleus and interacts with DNA binding proteins to regulate transcriptional responses (Figure 1 ). Smad partners include the DNA binding factors FoxH1, Mixer, c-jun, Lef-1/TCF, OAZ, as well as many others all of which are required for the regulation of specific target genes (Attisano and ten Dijke et al., 2000; Moustakas et al., 2001; Shi and Massague, 2003) . Smads can positively regulate gene expression by recruiting coactivators such as CBP/p300 or negatively by direct recruitment of histone deacetylases (HDACs) or corepressors, such as c-ski and SnoN, which themselves associate with HDACs (ten Moustakas et al., 2001; Attisano and Wrana, 2002; Shi and Massague, 2003) . In addition to R-Smads and co-Smads, the I-Smads or inhibitory Smads (Smad6 and -7) are crucial for appropriate regulation of TGFb and BMP signalling pathways. Smad6 and -7 block TGFb and BMP signalling by competing with R-Smads for association with type I receptors or by targeting receptors for ubiquitin-mediated degradation (Moustakas et al., 2001; Attisano and Wrana, 2002; Shi and Massague, 2003) .
Smads comprise two conserved globular domains, the N-terminal MH1 domain and C-terminal MH2 domain, which are separated by a proline-rich linker region (de Caestecker et al., 2000; Moustakas et al., 2001; Attisano and Wrana, 2002; Shi and Massague, 2003) . While the MH1 domain of R-Smads and Smad4 are highly conserved, the amino-terminal region of the ISmads only shows a weak sequence similarity with the MH1 domain of other Smads. The MH2 domain is highly conserved among all Smads, whereas the linker regions are divergent. Functionally, the MH1 domain is implicated in nuclear import, and DNA binding, whereas the MH2 domain is involved in receptor interaction and Smad oligomerization (de Caestecker et al., 2000; Moustakas et al., 2001; Attisano and Wrana, 2002; Shi and Massague, 2003) . The MH2 domain is also important for the cytoplasmic anchoring of Smads. The Smad anchor for receptor activation or SARA interacts with the MH2 of Smad2 and -3 and targets the R-Smads to the cell surface (Tsukazaki et al., 1998) . Moreover, SARA contains an FYVE domain, which mediates binding to phospholipids and targets Smads to early endosomes (Tsukazaki et al., 1998) . Both the MH1 and MH2 domains mediate interactions with transcription factors, and transcriptional coactivators or corepressors (Attisano and Wrana, 2000; Wotton and Massague´, 2000; Moustakas et al., 2001) . The linker region contains a number of phosphorylation sites crucial for crosstalk with other signalling pathways and a PY motif, which specifically interact with E3 ubiquitin ligases implicated in the regulation of the TGFb and BMP pathways (Attisano and Wrana, 2002) .
Although abundant evidence demonstrates that Smads are critical for TGFb family signalling, accumulating data suggests that Smad-independent pathways also exist (de Caestecker et al., 2000; Mulder, 2000) . For instance, TGFb has been reported to activate mitogenactivated protein kinases including the extracellularregulated kinases, c-Jun N-terminal kinases and p38 kinases. There is also evidence for TGFb-dependent activation of PKB/Akt through PI3 kinase, and a RhoA-dependent signalling pathway has been suggested to function in TGFb-mediated epithelial-mesenchymal transition (Bakin et al., 2000; Bhowmick et al., 2001) . As the molecular details of these signalling pathways are not well understood, they will not be considered further in this review.
Signalling-independent regulation of R-Smad protein levels by ubiquitination Smads are critical intracellular mediators of TGFb signalling pathways, and thus alterations in Smad protein levels can profoundly effect signalling. Consistent with this, the ubiquitin-proteasomal pathway has been shown to regulate the basal level of Smads (Figure 2 ). That the level of the Smad pool is regulated in a signalling-independent manner was first described for the R-Smad, Smad1. A yeast two-hybrid screen using Smad1 as bait identified Smad ubiquitinationrelated factor 1 (Smurf1) as an interacting protein (Zhu et al., 1999) . Smurf1 is an E3 ubiquitin ligase of the C2-WW-HECT domain class and contains an N-terminal C2 domain, two WW domains and a carboxy-terminal HECT domain that catalyses the transfer of the ubiquitin moiety to its target substrates (Figure 3) . The WW domains of Smurf1 mediate a specific interaction with the PY motif of the BMP-regulated Smad1 and -5 (Zhu et al., 1999) , thereby allowing Smurf1 to target Smad1 for ubiquitination and proteasomal degradation. Ectopic expression of Xenopus Smurf1 in combination with Smad1 in Xenopus animal caps results in the downregulation of Smad1-induced genes and the development of a secondary axis (Zhu et al., 1999) . Thus, Smurf1 appears to regulate BMP signalling by targeting nonactivated Smad1 and -5 for protein degradation, thereby preventing spurious activation of the pathway. This may be particularly important in a developmental context as it allows cells to be competent to respond to BMP stimulation only when appropriate (Zhu et al., 1999) . A second Smurf1-related E3 HECT domain ligase, termed Smurf2, has also been described (Kavsak et al., 2000; Lin et al., 2000; Zhang et al., 2001) . Alignment of the amino-acid sequences reveals that Smurf2 exhibits an overall sequence identity of 80% with Smurf1. Smurf2 features an N-terminal C2 domain, WW domains and a carboxy-terminal HECT ligase domain. Interestingly, while Smurf1 contains two WW domains, Smurf2 comprises three WW domains, resulting from a 31 amino-acid insertion downstream of the C2 domain ( Figure 2 ). Overexpression and in vitro studies have indicated that Smurf2 can associate with unactivated Smad1, -2 and -3 but not with the co-Smad, Smad4, which lacks a PY motif (Lin et al., 2000; Zhang et al., 2001) . Moreover, a decrease in the steadystate level of Smad1 and to a lesser degree Smad2 has been observed upon expression of Smurf2, suggesting that the R-Smad pool might be regulated by Smurf2. However, the association of Smad2 with Smurf2 is dramatically enhanced upon activation of the TGFb signalling pathway (Lin et al., 2000; Bonni et al., 2001) , suggesting that Smurf2 may be of particular importance for ligand-dependent regulation of the pathway (see below).
Signalling-dependent regulation of R-Smads by ubiquitination
In addition to regulating steady-state levels of R-Smads, the ubiquitin-proteasome pathway is involved in the degradation of activated R-Smads ( Figure 3 ). In human keratinocytes, endogenous Smad2 is targeted for ubiquitination and proteasomal degradation in response to TGFb stimulation (Lo and Massague´, 1999) . Destruction of activated Smad2 was shown to occur in the nucleus and was mediated by the E2-conjugating enzymes, UbcH5b/c and Ubc3 (Lo and Massague´, 1999) . As Smurf2 can associate with activated Smad2 (Lin et al., 2000; Bonni et al., 2001) , Smurf2 is a candidate E3 ligase for activated Smad2 degradation. However, the specific E3 ligase localized to the nucleus that catalyses the ligation of the ubiquitin moieties onto activated Smad2 has not yet been defined. Similar to Smad2, activated Smad3 is also targeted for proteasomal destruction. However, in this case, SCF/ Roc1 E3 ligase complex has been shown to be responsible for triggering the ubiquitination of phosphorylated Smad3 . Once bound to and ubiquitinated by the SCF/Roc1 complex, nuclear Smad3 is exported from the nucleus and undergoes proteasomal degradation in the cytoplasm. Interestingly, recruitment of the transcriptional coactivator p300 to activated Smad3 enhances the association between Smad3 and Roc1, suggesting that ubiquitindependent degradation of Smad3 may be necessary to terminate Smad3 transcriptional activity . The degradation of activated Smad1 has also been reported through a complex containing Smad1, the ornithine decarboxylase antizyme (Az) and the 20S proteasome b subunit, HsN3, which then targets Smad1 for proteasomal degradation (Gruendler et al., 2001) .
Ubiquitination of the common Smad, Smad4
Although the mechanism of Smad4 ubiquitination is not known, proteasomal degradation of the common Smad has also been described. For instance, ectopic expression of Jab1 (Jun-activating domain binding protein 1), which also induces degradation of p27 and p53, mediated ubiquitination and degradation of Smad4 (Wan et al., 2002) . Further, the overexpression of oncogenic Ras has been shown to decrease Smad4 Figure 3 Structural features of smurfs. A schematic representation of human Smurf1 (hSmurf1), human Smurf2 (hSmurf2) and Drosophila Smurf (Dsmurf) is shown. Amino-acid residues delineating distinct domains as defined by the ProSite database (http://ca.expasy.org) are indicated. All Smurfs contain an N-terminal C2 domain and a C-terminal HECT domain, and either two or three WW domains Regulation of the TGFb signalling L Izzi and L Attisano protein levels, an effect that was partially reversed by an inhibitor of the ubiquitin-proteasome pathway (Saha et al., 2001) . In addition to regulating the proteasomal degradation of Smad4, ubiquitination is also implicated in the modulation of Smad4 function. A recent report demonstrated that Smad4 is monoubiquitinated in its MH2 domain at lysine 507 (Moren et al., 2003) . Unlike polyubiquitination that targets proteins for proteasomal degradation, the role of monoubiquitination is less clear. In the case of Smad4, mutagenesis of lysine 507 leads to a weaker affinity for R-Smads and a lower ability to transactivate target promoters following TGFb stimulation (Moren et al., 2003) , suggesting that monoubiquitination enhances Smad4 transcriptional activity.
Sumoylation of Smads
Ubiquitination is not the sole modification that appears to modulate protein function. Among the ubiquitinlike proteins present in eukaryotic cells, the small ubiquitin-related modifier (SUMO) appears to be a versatile modifier of a growing number of proteins implicated in various signalling pathways (Desterro et al., 2000; Melchior, 2000; Muller et al., 2001; Schwartz and Hochstrasser, 2003) . Unlike ubiquitination, sumoylation does not target substrates for proteasomal degradation. Instead, SUMO conjugation appears to regulate protein-protein interaction, subnuclear localization, protein-DNA interaction, enzymatic activity and ubiquitin-dependent degradation (Melchior, 2000; Muller et al., 2001; Schwartz and Hochstrasser, 2003) . Recent studies demonstrate that the SUMO E3 ligase PIASy, protein inhibitor of activated STAT (signal transducers and activators of transcription), interacts and catalyses the sumoylation of Smad4 (Lee et al., 2003; Lin et al., 2003a, b; Long et al., 2003) . In addition to promoting the nuclear accumulation of Smad4, sumoylation appears to enhance Smad4 stability and Smad4-dependent transcriptional activity (Lee et al., 2003; Lin et al., 2003a, b) . Moreover, PIASy also modulates TGFb signalling by sumoylating Smad3 (Imoto et al., 2003) . The functional consequence of Smad3 sumoylation is not well understood. Possibly, the conjugation of SUMO to Smad3 may hinder the association of Smad3 with Smad4 or prevent Smad3 binding to target promoters. Further studies are clearly needed to delineate the role of sumoylation in the regulation of TGFb signalling.
R-Smads as adaptors for E3 ligases
While several studies have indicated that association of Smads with Smurf family ligases results in Smad degradation, accumulating evidence indicates that Smads also function as adaptors that recruit Smurfs to target proteins, and thereby control the level of Smadassociating proteins. Ski and SnoN are two closely related nuclear proto-oncogenes that bind Smads and antagonize TGFb signalling in part through their ability to recruit HDACs to block transcription (ten Dijke et al., 2000; Moustakas et al., 2001; Attisano and Wrana, 2002; Shi and Massague, 2003) . TGFb stimulation has been shown to result in the formation of a Smad2/ Smurf2 complex in which Smad2 then recruits Smurf2 to the transcriptional corepressor SnoN . Complex formation between Smurf2/Smad2 and SnoN then triggers the ubiquitination and degradation of SnoN . As SnoN is a negative regulator of TGFb transcriptional responses, its degradation may thereby restore TGFb signalling. Smads have been shown to function as adaptors for other E3 ligases that can also function to degrade SnoN. Smad3, and to a lesser extent Smad2, can associate with the anaphase-promoting complex (APC) and recruit it to SnoN upon activation of TGFb signalling Wan et al., 2001) . As with the Smurfs, recruitment of APC to SnoN Wan et al., 2001 ) results in the ubiquitination and proteasomal degradation of SnoN. The reason why Smad2/3 uses two distinct E3 ligase complexes to mediate SnoN degradation is yet unclear, but it may reflect differences in cell types or perhaps the timing of SnoN degradation. Smad3 has also been shown to promote the ubiquitination and degradation of the Cas family member HEF1, which functions as an adaptor protein in a number of signalling pathways (Liu et al., 2000) . Whether Smad3 mediates HEF1 degradation by recruiting an E3 ligase is still unclear.
I-Smads as adaptors for Smurfs
The regulation of cellular processes requires the activation of specific signalling pathways. However, equally important is the downregulation of the signal. The I-Smads play a pivotal role in this regard as they bind directly to Ser/Thr kinase receptors and thereby block R-Smad access to the receptor (Moustakas et al., 2001; Attisano and Wrana, 2002; Shi and Massague, 2003) . The demonstration that I-Smads bind to the Smurf family of E3 ligases has revealed an additional mechanism whereby I-Smads can interfere with TGFb signalling. Specifically, I-Smads can function as adaptors to recruit Smurfs to the receptor complex and thereby mediate receptor degradation and downregulation of TGFb signalling.
The expression of Smad7 is regulated by a number of extracellular signals and both TGFb and BMPs have been shown to increase Smad7 protein levels, particularly in the nucleus where Smad7 is preferentially localized (Itoh et al., 1998; Moustakas et al., 2001; Attisano and Wrana, 2002; Shi and Massague, 2003) . Smurf2 resides in the nucleus in unstimulated cells and thus the increase in Smad7 protein levels results in the association of Smad7 with Smurf2 (Kavsak et al., 2000) . This interaction is mediated by the PY motif in Smad7 and the WW2/WW3 domains of Smurf2. The Smad7/Smurf2 complex is then exported from the nucleus to the cytoplasm where Smad7 then recruits Smurf2 to the TGFb receptor complex at the cell surface. Once bound to the receptor complex, the Smurfs ubiquitinate Smad7 and cause degradation of both Smad7 and the receptor complex (Figure 4 ) (Kavsak et al., 2000) . Smurf1 can also interact with Smad7 and be targeted to the TGFb receptor to mediate the turnover of the receptor complex . In this case, it has been shown that chromosomal region maintenance 1, an importin b-related nuclear transport receptor, physically interacts with a nuclear export signal present within HECT domain of Smurf1 and thereby mediates the nuclear export of the Smurf1/ Smad7 complex (Suzuki et al., 2002; Tajima et al., 2003) . Both of the I-Smads, Smad6 and -7, have also been shown to function as adaptors that recruit Smurf1 to BMP receptor complexes and mediate BMP receptor complex turnover (Murakami et al., 2003) . The physiological specificity of Smad6 and -7 association with Smurf1 and/or Smurf2 to target either TGFb or BMP receptor complex turnover has not been resolved, but it may be that different I-Smad/Smurf combinations serve similar functions in different cell types or tissues. An additional level of complexity in Smad/Smurf-dependent regulation of TGFb signalling was recently revealed with the demonstration that Smad7 is acetylated by the transcriptional activator p300 (Gronroos et al., 2002) . This acetyltransferase targets two lysine residues in the amino-terminus of Smad7, which serves to protect Smad7 from Smurf1-mediated ubiquitination. Acetylation did not appear to alter Smad7 nuclear export and thus may not interfere with subsequent targeting of the Smad7/Smurf1 complex to the TGFb receptor complex (Gronroos et al., 2002) . Instead, acetylation may serve to protect Smad7 from premature degradation by Smurfs. It will be interesting to determine whether other Smads are also similarly stabilized.
The ubiquitin-proteasome pathway also plays an important role in controlling TGFb receptor trafficking (Di Guglielmo et al., 2003) . TGFb receptors can be internalized via two distinct routes, a clathrin-and a raft/caveolar-dependent pathway each of which has distinct outcomes. Receptors that are internalized via the clathrin pathway enter the EEA1-positive early endosome where SARA is also enriched. Receptors that enter this compartment are competent to transduce TGFb signals (Ehrlich et al., 2001; Hayes et al., 2002; Penheiter et al., 2002; Di Guglielmo et al., 2003) . In contrast, the receptor complex that is found in lipid-rich raft domains of the plasma membrane associates with the Smad7/Smurf2 complex (Di Guglielmo et al., 2003) . Here, the receptor complex is internalized into a caveolin-positive compartment that leads to the degradation of the receptor complex (Figure 4) . It is likely that it is the balance of receptor partitioning between these two pathways that underlies the variable requirement for clathrin in TGFb signalling (Lu et al., 2002; Di Guglielmo et al., 2003) . What causes receptors to segregate between these two routes is unclear since TGFb ligand does not appear to strongly affect partitioning and endocytosis into either intracellular compartment.
Biological role of Smurfs
While the biochemical activity of Smurfs has been extensively examined, much less is known of their biological role. A recent report has revealed that the overexpression of Smurf1 blocks BMP-induced osteogenic conversion in C2C12 myoblasts and can facilitate myogenic differentiation by inducing the degradation of Smad5 (Ying et al., 2003) . Smurf1 has also been reported to induce the proteasomal destruction of Cbfa, a transcription factor of the runt-domain gene family implicated in osteoblast differentiation and bone development (Zhao et al., 2003) . Interestingly, the overexpression of a catalytic mutant of Smurf1, unable to target Cbfa1 nor Smad1 for ubiquitin-dependent proteasomal degradation, enhanced osteoblast differentiation in C2C12 cells (Zhao et al., 2003) . In addition, a recent study has shown that Smurf1 can regulate cell polarity and the formation of cellular protrusions through its ability to target the GTPase, RhoA for degradation . To date mice null for Smurf1 or Smurf2 have not yet been generated; however, insights into the in vivo role of Smurfs have been provided by studies in Drosophila. Podos et al. (2001) identified Drosophila Smurf (DSmurf, Figure 3 ) and found that it acts as a negative regulator of decapentaplegic (Dpp) signalling in the fly. Dpp, the ortholog of BMP2/4 in Drosophila, confers positional information in both the wing disc and the embryonic ectoderm. Dpp mRNA is produced uniformly across the dorsal region of the embryo (Arora et al., 1994) ; however, Dpp gradient activity is required to establish proper dorso-ventral (D-V) patterning in the embryonic ectoderm. While a number of molecules function to establish and maintain a Dpp gradient extracellularly, DSmurf appears to function intracellularly to regulate Dpp signalling. DSmurf mutant embryos do not present any overt disturbance in D-V patterning of their cuticle; however, spatial expansion of Dpp signalling is observed (Podos et al., 2001) . DSmurf mutant embryos show increased staining of phosphorylated MAD, a Smad protein, along the D-V axis and increased expression of the Dpp target genes zerknu¨llt (zen), Race and u-shaped (ush) (Podos et al., 2001) . Therefore, it appears that one function of DSmurf is to regulate the level of Dpp signalling along the D-V axis, thereby contributing to the establishment of an activity gradient. Mutation of the DSmurf locus also results in the appearance of a posterior hole in the cuticle of the embryo that results from a hindgut defect, which likely interferes with dorsal closure of the cuticle. A prolonged phospho-MAD staining is observed in the hindgut and this correlates with the ectopic expression of Dpp target genes, such as zen (Podos et al., 2001) . Therefore, the morphological defect in the cuticle is likely due to a temporal deregulation of Dpp signalling in the hindgut (Podos et al., 2001) . Thus, DSmurf appears to be important for both establishment of Dpp gradient and for temporal control of Dpp signalling.
Ubiquitination and degradation of oncogenic Smad mutants
By regulating the steady-state levels of nonactivated Smads, ubiquitin-dependent protein degradation has proven to be essential in maintaining the basal state of the TGFb and BMP signalling pathways. Furthermore, by targeting the activated receptor complex and phosphorylated R-Smads for destruction, it is also an important mechanism for turning off TGFb signalling following the completion of the transcriptional response. A growing body of work indicates that ubiquitination and proteasomal degradation is implicated in the turnover of tumor-derived Smad mutants. Several inactivating mutations in Smad2 and -4 have been identified in a variety of human tumors, including pancreatic, colorectal and lung carcinomas (de Caestecker et al., 2000; Derynck et al., 2001) . Although the majority of missense and nonsense mutations identified in Smads are localized in the MH2 domains, a number of missense mutations have also been described in the MH1 domains. Interestingly, some of these oncogenic mutations in Smads do not affect their ability to be phosphorylated, oligomerize, translocate or carry out their transcriptional functions, rather they appear to affect the steady-state levels of the protein (Moren et al., 2000; Xu and Attisano, 2000; Moren et al., 2003) . Missense mutations in the MH1 domain of tumor-derived Smad4, including L43S, G65V, R100T and P130S, lead to increased polyubiquitination and proteasomal degradation of Smad4 when compared to the wild-type protein (Moren et al., 2000; Xu and Attisano, 2000; Moren et al., 2003) . Similarly, an arginine-to-cysteine mutation at position 133 in the MH1 domain of Smad2 also causes an increase in the degradation of Smad2 (Xu and Attisano, 2000) . A nonsense mutation at position 515 in the MH2 domain of Smad4, found in pancreatic adenocarcinomas, which results in the truncation of the last 38 amino acids, targets Smad4 for ubiquitin-dependent proteasomal degradation in addition to preventing it from associating with Smad2 and binding DNA (Maurice et al., 2001) . A missense mutation found in human hepatocellular carcinoma in which Smad2 harbors a glutamine-to-arginine mutation at position 407 in the MH2 and a colorectal cancer-associated mutation in leucine 369 to arginine have also proved to be highly unstable and, in the case of Q407R, has been shown to result in rapid ubiquitin-dependent degradation of the mutant Smad (Eppert et al., 1996; Dumont et al., 2003) . Taken together, these observations suggest that certain oncogenic mutations in Smads inactivate the proteins by enhancing their polyubiquitination and proteasomal destruction, and may thus cause abnormal TGFb signalling, deregulated cell proliferation and promote tumorigenesis.
Since E3 ubiquitin ligases control the localization, activity and stability of numerous components of TGFb signalling, dysregulated expression or function of E3 ubiquitin ligases may profoundly affect the proper transmission of TGFb signals and thus may contribute to the development of human diseases. Consistent with this possibility, a recent study by Fukuchi et al. (2002) demonstrated that high-level expression of Smurf2 is associated with oesophageal squamous carcinoma and a poor prognosis for patients with the disease. Although TGFb functions as a tumor suppressor in early stages of cancer progression, abundant evidence indicates that increased TGFb signalling can promote late-stage tumors (de Caestecker et al., 2000; Derynck et al., 2001) . Thus, a decrease in Smurf levels with a concomitant increase in TGFb signalling might also promote tumorigenesis. RNF11, a RING-H2 protein that is highly expressed in invasive breast cancer, was recently shown to interact with Smurf2 (Subramaniam et al., 2003) . Ectopic expression of RNF11 appears to block Smurf2-dependent inhibition of TGFb signalling possibly by promoting Smurf2 ubiquitination and degradation via the ubiquitin-proteasomal pathway. By blocking Smurf2 activity, RNF11 may thus enhance TGFb signalling and its tumor-promoting activity.
Conclusions
The ubiquitin-mediated proteasomal degradation pathway is an evolutionary conserved cascade involved in the regulation of key cellular processes, such as signal transduction, cell cycle progression, transcriptional regulation and endocytosis (Hershko and Ciechanover, 1998) . Like other signalling pathways, the TGFb and BMP pathways are tightly regulated by the ubiquitin-proteasomal degradation system and this occurs through a variety of mechanisms. The ubiquitin pathway can regulate the basal level of Smads and as Smads are privotal for transducing TGFb signals, alterations in Smad proteins can profoundly affect the capacity of cells to respond to incoming signals. Smads are also targeted for ubiquitination and degradation in response to TGFb stimulation and this then contributes to the termination of TGFb signals. The E3 ligases, including Roc1, Smurf1 and Smurf2, have been implicated in Smad degradation, but the Smurf family of C2-WW-HECT domain ligases has gained particular prominence as they also control the degradation of other components of the TGFb signalling pathway. For instance, the I-Smads recruit Smurfs to the TGFb receptor complex where they contribute to receptor compartmentalization and promote receptor degradation, thereby downregulating TGFb signalling. The R-Smads can also recruit E3 ligases including Smurf2 and APC to mediate the degradation of a negative transcriptional regulator of the pathway, SnoN. Thus, ubiquitin-mediated degradation of a Smad-associated protein would be predicted to result in enhanced activation of SnoN targeted genes. Undoubtedly, current and future research endeavors will shed light as to how degradation of TGFb pathway components by Smurfs and other E3 ligases contributes to the complexity of biological responses to TGFb superfamily ligands. Several studies have shown that turnover of Smads harboring tumor-associated mutations are regulated by ubiquitination and degradation (Moren et al., 2000; Xu and Attisano, 2000; Moren et al., 2003) . Furthermore, a correlation between Smurf2 expression and poor prognosis in oesophageal squamous carcinoma has been observed . Thus, one intriguing possibility is that the Smurf family of E3 ligases may represent suitable targets for anticancer drug development.
